The goal of this clinical trial is to learn if transcutaneous auricular vagus nerve stimulation (taVNS) works to reduce perceived stress and psychological distress in university students with high distress levels. The main questions it aims to answer are: * Does taVNS reduce perceived stress (measured by PSS-10) in university students with high psychological distress? * Does taVNS reduce psychological distress (measured by K10) in university students with high psychological distress? * Is the intervention feasible and tolerable for implementation in higher-education mental health support? Researchers will compare taVNS (electrode placed on the left tragus) to a sham stimulation group (electrode placed on the left earlobe) to see if taVNS reduces stress and distress. Participants will: * Attend five consecutive daily 30-minute stimulation sessions * Complete stress and distress questionnaires before the intervention, immediately after, and at 1-month follow-up * Receive electrical stimulation at individually adjusted intensity using the Nurosym device (pulse width 250 µs, frequency 20 Hz).
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Psychological Distress (K10)
Timeframe: Baseline (pre-intervention), immediately post-intervention (after 5 daily sessions, approximately day 5), and 1-month follow-up
Perceived Stress (PSS-10)
Timeframe: Baseline (pre-intervention), immediately post-intervention (after 5 daily sessions, approximately day 5), and 1-month follow-up
Feasibility (Retention Rate)
Timeframe: From randomization through 1-month follow-up
Tolerability (Adverse Events / Dropout Due to AEs)
Timeframe: From the first to the fifth stimulation session (Days 1-5), with adverse events assessed immediately before and after each intervention session.